176 related articles for article (PubMed ID: 26176859)
1. Early Diagnosis and Monitoring of Neurodegenerative Langerhans Cell Histiocytosis.
Sieni E; Barba C; Mortilla M; Savelli S; Grisotto L; Di Giacomo G; Romano K; Fonda C; Biggeri A; Guerrini R; Aricò M
PLoS One; 2015; 10(7):e0131635. PubMed ID: 26176859
[TBL] [Abstract][Full Text] [Related]
2. Pattern and course of neurodegeneration in Langerhans cell histiocytosis.
Wnorowski M; Prosch H; Prayer D; Janssen G; Gadner H; Grois N
J Pediatr; 2008 Jul; 153(1):127-32. PubMed ID: 18571550
[TBL] [Abstract][Full Text] [Related]
3. CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions.
McClain KL; Picarsic J; Chakraborty R; Zinn D; Lin H; Abhyankar H; Scull B; Shih A; Lim KPH; Eckstein O; Lubega J; Peters TL; Olea W; Burke T; Ahmed N; Hicks MJ; Tran B; Jones J; Dauser R; Jeng M; Baiocchi R; Schiff D; Goldman S; Heym KM; Wilson H; Carcamo B; Kumar A; Rodriguez-Galindo C; Whipple NS; Campbell P; Murdoch G; Kofler J; Heales S; Malone M; Woltjer R; Quinn JF; Orchard P; Kruer MC; Jaffe R; Manz MG; Lira SA; Parsons DW; Merad M; Man TK; Allen CE
Cancer; 2018 Jun; 124(12):2607-2620. PubMed ID: 29624648
[TBL] [Abstract][Full Text] [Related]
4. Long-term MR imaging course of neurodegenerative Langerhans cell histiocytosis.
Prosch H; Grois N; Wnorowski M; Steiner M; Prayer D
AJNR Am J Neuroradiol; 2007; 28(6):1022-8. PubMed ID: 17569949
[TBL] [Abstract][Full Text] [Related]
5. Central diabetes insipidus as the inaugural manifestation of Langerhans cell histiocytosis: natural history and medical evaluation of 26 children and adolescents.
Marchand I; Barkaoui MA; Garel C; Polak M; Donadieu J;
J Clin Endocrinol Metab; 2011 Sep; 96(9):E1352-60. PubMed ID: 21752883
[TBL] [Abstract][Full Text] [Related]
6. Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis.
Grois N; Prayer D; Prosch H; Minkov M; Pötschger U; Gadner H
Pediatr Blood Cancer; 2004 Jul; 43(1):59-65. PubMed ID: 15170891
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of hypothalamic pituitary tumors in Langerhans cell histiocytosis.
Fahrner B; Prosch H; Minkov M; Krischmann M; Gadner H; Prayer D; Grois N
Pediatr Blood Cancer; 2012 Apr; 58(4):606-10. PubMed ID: 22183971
[TBL] [Abstract][Full Text] [Related]
8. Treatment of multisystem Langerhans cell histiocytosis. Results of the DAL-HX 83 and DAL-HX 90 studies. DAL-HX Study Group.
Minkov M; Grois N; Heitger A; Pötschger U; Westermeier T; Gadner H
Klin Padiatr; 2000; 212(4):139-44. PubMed ID: 10994540
[TBL] [Abstract][Full Text] [Related]
9. MRI features of neurodegenerative Langerhans cell histiocytosis.
Martin-Duverneuil N; Idbaih A; Hoang-Xuan K; Donadieu J; Genereau T; Guillevin R; Chiras J;
Eur Radiol; 2006 Sep; 16(9):2074-82. PubMed ID: 16625352
[TBL] [Abstract][Full Text] [Related]
10. Langerhans cell histiocytosis of spine: a comparative study of clinical, imaging features, and diagnosis in children, adolescents, and adults.
Huang WD; Yang XH; Wu ZP; Huang Q; Xiao JR; Yang MS; Zhou ZH; Yan WJ; Song DW; Liu TL; Jia NY
Spine J; 2013 Sep; 13(9):1108-17. PubMed ID: 23602327
[TBL] [Abstract][Full Text] [Related]
11. MRI and clinical features of Langerhans cell histiocytosis (LCH) in the pelvis and extremities: can LCH really look like anything?
Samet J; Weinstein J; Fayad LM
Skeletal Radiol; 2016 May; 45(5):607-13. PubMed ID: 26802000
[TBL] [Abstract][Full Text] [Related]
12. Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside.
Allen CE; Flores R; Rauch R; Dauser R; Murray JC; Puccetti D; Hsu DA; Sondel P; Hetherington M; Goldman S; McClain KL
Pediatr Blood Cancer; 2010 Mar; 54(3):416-23. PubMed ID: 19908293
[TBL] [Abstract][Full Text] [Related]
13. Recognition and treatment of concurrent active and neurodegenerative langerhans cell histiocytosis: a case report.
Ehrhardt MJ; Karst J; Donohoue PA; Maheshwari M; McClain KL; Bingen K; Kelly ME
J Pediatr Hematol Oncol; 2015 Jan; 37(1):e37-40. PubMed ID: 24322503
[TBL] [Abstract][Full Text] [Related]
14. Treatment of neurodegenerative CNS disease in Langerhans cell histiocytosis with a combination of intravenous immunoglobulin and chemotherapy.
Imashuku S; Okazaki N'; Nakayama M; Fujita N; Fukuyama T; Koike K; Minato T; Kobayashi R; Morimoto A;
Pediatr Blood Cancer; 2008 Feb; 50(2):308-11. PubMed ID: 17458874
[TBL] [Abstract][Full Text] [Related]
15. Whole-body MRI of Langerhans cell histiocytosis: comparison with radiography and bone scintigraphy.
Goo HW; Yang DH; Ra YS; Song JS; Im HJ; Seo JJ; Ghim T; Moon HN
Pediatr Radiol; 2006 Oct; 36(10):1019-31. PubMed ID: 16896695
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study.
Héritier S; Barkaoui MA; Miron J; Thomas C; Moshous D; Lambilliotte A; Mazingue F; Kebaili K; Jeziorski E; Plat G; Aladjidi N; Pacquement H; Galambrun C; Brugières L; Leverger G; Mansuy L; Paillard C; Deville A; Pagnier A; Lutun A; Gillibert-Yvert M; Stephan JL; Cohen-Aubart F; Haroche J; Pellier I; Millot F; Gandemer V; Martin-Duverneuil N; Taly V; Hélias-Rodzewicz Z; Emile JF; Hoang-Xuan K; Idbaih A; Donadieu J
Br J Haematol; 2018 Nov; 183(4):608-617. PubMed ID: 30421536
[TBL] [Abstract][Full Text] [Related]
17. Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study.
Chellapandian D; Shaikh F; van den Bos C; Somers GR; Astigarraga I; Jubran R; Degar B; Carret AS; Mandel K; Belletrutti M; Dix D; Visser J; Abuhadra N; Chang T; Rollins B; Whitlock J; Weitzman S; Abla O
Pediatr Blood Cancer; 2015 Dec; 62(12):2162-6. PubMed ID: 26179251
[TBL] [Abstract][Full Text] [Related]
18. Strategies for the Prevention of Central Nervous System Complications in Patients with Langerhans Cell Histiocytosis: The Problem of Neurodegenerative Syndrome.
Imashuku S; Arceci RJ
Hematol Oncol Clin North Am; 2015 Oct; 29(5):875-93. PubMed ID: 26461148
[TBL] [Abstract][Full Text] [Related]
19. Pituitary stalk thickening with diabetes insipidus preceding typical manifestations of Langerhans cell histiocytosis in children.
Schmitt S; Wichmann W; Martin E; Zachmann M; Schoenle EJ
Eur J Pediatr; 1993 May; 152(5):399-401. PubMed ID: 8319704
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and treatment outcomes of Langerhans cell histiocytosis of the spine.
Xu X; Han S; Jiang L; Yang S; Liu X; Yuan H; Wei F; Wu F; Dang L; Zhou H; Zhang H; Liu Z
Spine J; 2018 Oct; 18(10):1755-1762. PubMed ID: 29505854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
